Trials / Conditions / Respiratory Syncytial Virus Vaccination
Respiratory Syncytial Virus Vaccination
3 registered clinical trials studyying Respiratory Syncytial Virus Vaccination — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults NCT06984094 | Clover Biopharmaceuticals AUS Pty | Phase 1 |
| Completed | A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and NCT06850051 | Sanofi | Phase 1 |
| Completed | First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults NCT06194318 | Clover Biopharmaceuticals AUS Pty | Phase 1 |